50 results on '"Trevisini, Sara"'
Search Results
2. Sporotrichoid Mycobacterium marinum infection in an elderly woman
- Author
-
di Meo, Nicola, Stinco, Giuseppe, Trevisini, Sara, De Marchi, Sergio, Albano, Antonio, and Trevisan, Giusto
- Abstract
We describe the case of an elderly woman who acquired a Mycobacterium marinum infection following skin exposure to the bacteria through a small wound on her right ring finger, obtained while preparing fish. The resultant sporotrichoid nodules of the right hand and the distal forearm, refractory to the initial therapy with doxycycline and rifampicin, were successfully treated with oral regimen of clarithromycin.
- Published
- 2015
3. Giant melanoma of the abdomen: case report and revision of the published cases
- Author
-
di Meo, Nicola, Stinco, Giuseppe, Gatti, Alessandro, Errichetti, Enzo, Bonin, Serena, Albano, Antonio, Trevisini, Sara, and Trevisan, Guisto
- Abstract
Malignant melanoma presenting as a giant cutaneous mass is rarely observed in clinical practice. A few patients with giant melanoma have been reported, Herein, we document our experience with a patient with giant cutaneous melanoma of the abdomen and review the features of previously reported individuals.
- Published
- 2014
4. Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
- Author
-
Talamonti, Marina, primary, Russo, Filomena, additional, Malara, Giovanna, additional, Hansel, Katharina, additional, Papini, Manuela, additional, Cattaneo, Angelo, additional, Parodi, Aurora, additional, Chiricozzi, Andrea, additional, Malagoli, Piergiorgio, additional, Bardazzi, Federico, additional, Brazzelli, Valeria, additional, Dapavo, Paolo, additional, Gisondi, Paolo, additional, Zane, Cristina, additional, Potenza, Concetta, additional, Cantoresi, Franca, additional, Fargnoli, Maria Concetta, additional, Trevisini, Sara, additional, Brianti, Pina, additional, Pescitelli, Leonardo, additional, Gigante, Giovanni, additional, Bartezaghi, Marta, additional, Caputo, Luisa, additional, Aloisi, Elisabetta, additional, and Costanzo, Antonio, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
- Author
-
Talamonti,Marina, Russo,Filomena, Malara,Giovanna, Hansel,Katharina, Papini,Manuela, Cattaneo,Angelo, Parodi,Aurora, Chiricozzi,Andrea, Malagoli,Piergiorgio, Bardazzi,Federico, Brazzelli,Valeria, Dapavo,Paolo, Gisondi,Paolo, Zane,Cristina, Potenza,Concetta, Cantoresi,Franca, Fargnoli,Maria Concetta, Trevisini,Sara, Brianti,Pina, Pescitelli,Leonardo, Gigante,Giovanni, Bartezaghi,Marta, Caputo,Luisa, Aloisi,Elisabetta, Costanzo,Antonio, Talamonti,Marina, Russo,Filomena, Malara,Giovanna, Hansel,Katharina, Papini,Manuela, Cattaneo,Angelo, Parodi,Aurora, Chiricozzi,Andrea, Malagoli,Piergiorgio, Bardazzi,Federico, Brazzelli,Valeria, Dapavo,Paolo, Gisondi,Paolo, Zane,Cristina, Potenza,Concetta, Cantoresi,Franca, Fargnoli,Maria Concetta, Trevisini,Sara, Brianti,Pina, Pescitelli,Leonardo, Gigante,Giovanni, Bartezaghi,Marta, Caputo,Luisa, Aloisi,Elisabetta, and Costanzo,Antonio
- Abstract
Marina Talamonti,1 Filomena Russo,2 Giovanna Malara,3,4 Katharina Hansel,5 Manuela Papini,6 Angelo Cattaneo,7 Aurora Parodi,8 Andrea Chiricozzi,9,10 Piergiorgio Malagoli,11 Federico Bardazzi,12 Valeria Brazzelli,13 Paolo Dapavo,14 Paolo Gisondi,15 Cristina Zane,16 Concetta Potenza,17 Franca Cantoresi,18 Maria Concetta Fargnoli,19 Sara Trevisini,20 Pina Brianti,21 Leonardo Pescitelli,22 Giovanni Gigante,23 Marta Bartezaghi,23 Luisa Caputo,23 Elisabetta Aloisi,23 Antonio Costanzo24,25 On behalf of the SUPREME Study Group1Dermatology, University of Rome Tor Vergata, Rome, Italy; 2Department of Medical, Surgical and Neurological Science, Dermatology Section, University of Siena, S. Maria alle Scotte Hospital, Siena, Italy; 3Dermatology Unit, Hospital âBianchi Melacrino Morelliâ, Reggio, Calabria, Italy; 4Department of Dermatology, Papardo Hospital, Messina, Italy; 5Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 6Dermatologic Clinic of Terni, Department of Medicine and Surgery, University of Perugia, Perugia, Italy; 7U.O. Dermatologia, Fondazione IRCCS Caâ Granda - Ospedale Maggiore Policlinico, Milano, Italy; 8Di.S.Sal. Section of Dermatology, Ospedale Policlinico San Martino, University of Genova, Genova GE, 16132, Italy; 9UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy; 10Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy; 11Psocare Unit, I.R.C.C.S Policlinico San Donato, Milano, Italy; 12Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 13Dermatology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy; 14Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Torino, Torino, Italy; 15Section of Dermatology and Venereology, Department of Medicine, University
- Published
- 2023
6. Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
- Author
-
Stingeni,Luca, Malara,Giovanna, Conti,Andrea, Di Costanzo,Luisa, Carrera,Carlo Giovanni, Burlando,Martina, Malagoli,Piergiorgio, Musumeci,Maria Letizia, Bardazzi,Federico, Brazzelli,Valeria, Amerio,Paolo, De Simone,Clara, Trevisini,Sara, Balato,Anna, Megna,Matteo, Loconsole,Francesco, De Felice,Catia, Bartezaghi,Marta, Rausa,Alice, Aloisi,Elisabetta, Orsenigo,Roberto, Costanzo,Antonio, Stingeni,Luca, Malara,Giovanna, Conti,Andrea, Di Costanzo,Luisa, Carrera,Carlo Giovanni, Burlando,Martina, Malagoli,Piergiorgio, Musumeci,Maria Letizia, Bardazzi,Federico, Brazzelli,Valeria, Amerio,Paolo, De Simone,Clara, Trevisini,Sara, Balato,Anna, Megna,Matteo, Loconsole,Francesco, De Felice,Catia, Bartezaghi,Marta, Rausa,Alice, Aloisi,Elisabetta, Orsenigo,Roberto, and Costanzo,Antonio
- Abstract
Luca Stingeni,1 Giovanna Malara,2,3 Andrea Conti,4 Luisa Di Costanzo,5 Carlo Giovanni Carrera,6 Martina Burlando,7 Piergiorgio Malagoli,8 Maria Letizia Musumeci,9 Federico Bardazzi,10 Valeria Brazzelli,11 Paolo Amerio,12 Clara De Simone,13,14 Sara Trevisini,15 Anna Balato,16 Matteo Megna,17 Francesco Loconsole,18 Catia De Felice,19 Marta Bartezaghi,20 Alice Rausa,20 Elisabetta Aloisi,20 Roberto Orsenigo,20 Antonio Costanzo21,22 On behalf of the SUPREME Study Group1Dermatology Section, Medical and Surgical Department, University of Perugia, Perugia, Italy; 2Dermatology Unit, Hospital âBianchi Melacrino Morelliâ, Reggio Calabria, Italy; 3Department of Dermatology, Papardo Hospital, Messina, Italy; 4Dermatologic Unit, Department of Surgery, Infermi Hospital, AUSL Romagna, Rimini, Italy; 5Department of Dermatology, âGaetano Rummoâ Hospital, Benevento UOC Dermatologia, AO G. Rummo, Benevento, Italy; 6U.O. Dermatologia, Fondazione IRCCS Caâ Granda - Ospedale Maggiore Policlinico, Milano, Italy; 7IRCCS San Martino Polyclinic Hospital, Di.S.Sal. Section of Dermatology, Genoa, Italy; 8Dermatology Unit IRCCS Policlinico San Donato, Milan, Italy; 9Dermatology Clinic, University of Catania, Catania, Italy; 10Division of Dermatology, University Hospital Policlinico âS. Orsola-Malpighiâ, Bologna, Italy; 11Institute of Dermatology, Foundation IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy; 12Dermatologic Clinic, G. DâAnnunzio University, Chieti, Italy; 13Istituto di Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy; 14Fondazione Policlinico Universitario A. Gemelli â IRCCS, Rome, Italy; 15Dermatology Department, University of Trieste, Trieste, Italy; 16Dermatology Unit, University of Campania âLuigi Vanvitelliâ, Naples, Italy; 17Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 18Department of Biomedical Sciences and Human Oncology, University of Bari, Bari
- Published
- 2023
7. Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
- Author
-
Stingeni, Luca, primary, Malara, Giovanna, additional, Conti, Andrea, additional, Di Costanzo, Luisa, additional, Carrera, Carlo Giovanni, additional, Burlando, Martina, additional, Malagoli, Piergiorgio, additional, Musumeci, Maria Letizia, additional, Bardazzi, Federico, additional, Brazzelli, Valeria, additional, Amerio, Paolo, additional, De Simone, Clara, additional, Trevisini, Sara, additional, Balato, Anna, additional, Megna, Matteo, additional, Loconsole, Francesco, additional, De Felice, Catia, additional, Bartezaghi, Marta, additional, Rausa, Alice, additional, Aloisi, Elisabetta, additional, Orsenigo, Roberto, additional, and Costanzo, Antonio, additional
- Published
- 2023
- Full Text
- View/download PDF
8. Adamantiades-Behçet disease: from clinical heterogeneity to diagnosis during the COVID-19 pandemic
- Author
-
TREVISAN, Giusto, primary, TREVISINI, Sara, additional, BERGAMO, Serena, additional, MEO, Nicola di, additional, BONIN, Serena, additional, RUSCIO, Maurizio, additional, MARINI, Marino, additional, GAGGINO, Andrea, additional, URBAN, Flavia, additional, and PASCAZIO, Lorenzo, additional
- Published
- 2022
- Full Text
- View/download PDF
9. Case Report: Lyme Borreliosis and Pregnancy - Our Experience
- Author
-
Trevisan, Giusto, primary, Ruscio, Maurizio, additional, di Meo, Nicola, additional, Nan, Katiuscia, additional, Cinco, Marina, additional, Trevisini, Sara, additional, Forgione, Patrizia, additional, and Bonin, Serena, additional
- Published
- 2022
- Full Text
- View/download PDF
10. Adamantiades‐Behçet 's disease therapy: current treatment options and recommendations with regard to the COVID ‐19 pandemic
- Author
-
Trevisini, Sara, primary, Trevisan, Giusto, additional, Zalaudek, Iris, additional, and Bonin, Serena, additional
- Published
- 2022
- Full Text
- View/download PDF
11. Borreliae Part 2: Borrelia Relapsing Fever Group and Unclassified Borrelia
- Author
-
Trevisan, Giusto, primary, Cinco, Marina, additional, Trevisini, Sara, additional, di Meo, Nicola, additional, Ruscio, Maurizio, additional, Forgione, Patrizia, additional, and Bonin, Serena, additional
- Published
- 2021
- Full Text
- View/download PDF
12. Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
- Author
-
Costanzo, Antonio, primary, Russo, Filomena, additional, Galluzzo, Marco, additional, Stingeni, Luca, additional, Scuderi, Roberta, additional, Zichichi, Leonardo, additional, Papini, Manuela, additional, Di Costanzo, Luisa, additional, Conti, Andrea, additional, Burlando, Martina, additional, Chiricozzi, Andrea, additional, Gaiani, Francesca Maria, additional, Mugheddu, Cristina, additional, Musumeci, Maria Letizia, additional, Gisondi, Paolo, additional, Piaserico, Stefano, additional, Dapavo, Paolo, additional, Venturini, Marina, additional, Pagnanelli, Gianluca, additional, Amerio, Paolo, additional, Potenza, Concetta, additional, Peris, Ketty, additional, Cantoresi, Franca, additional, Trevisini, Sara, additional, Loconsole, Francesco, additional, Offidani, Annamaria, additional, Mercuri, Santo Raffaele, additional, Lora, Viviana, additional, Prignano, Francesca, additional, Bartezaghi, Marta, additional, Oliva, Giovanni, additional, Aloisi, Elisabetta, additional, and Orsenigo, Roberto, additional
- Published
- 2021
- Full Text
- View/download PDF
13. Borreliae Part 1: Borrelia Lyme Group and Echidna-Reptile Group
- Author
-
Trevisan, Giusto, primary, Cinco, Marina, additional, Trevisini, Sara, additional, di Meo, Nicola, additional, Chersi, Karin, additional, Ruscio, Maurizio, additional, Forgione, Patrizia, additional, and Bonin, Serena, additional
- Published
- 2021
- Full Text
- View/download PDF
14. Electrochemotherapy as a novel treatment for primary cutaneous marginal zone B-cell lymphomas
- Author
-
Gatti, Alessandro, Stinco, Giuseppe, Trevisini, Sara, di Meo, Nicola, Signoretto, Diego, Leonardo, Eugenio, Bonin, Serena, and Trevisan, Giusto
- Published
- 2014
- Full Text
- View/download PDF
15. Adamantiades‐Behçet's disease therapy: current treatment options and recommendations with regard to the COVID‐19 pandemic.
- Author
-
Trevisini, Sara, Trevisan, Giusto, Zalaudek, Iris, and Bonin, Serena
- Subjects
- *
BEHCET'S disease , *COVID-19 pandemic , *TUMOR necrosis factors , *IMMUNOSUPPRESSIVE agents , *INTERFERON alpha , *COLCHICINE - Abstract
Adamantiades‐Behçet's disease (ABD) is a chronic, idiopathic, relapsing immune‐mediate disease that may involve multiple organs. It is characterized by recurrent oral and genital ulcers, skin lesions, ocular, gastrointestinal, vascular, neurological and joint involvement. It can lead to significant morbidity and mortality. Due to its heterogeneity in clinical findings and physiopathology, its treatment can be various as ABD manifestations in different organs may differently respond to the same drug. The cornerstone of therapy for inducing remission is systemic corticosteroid, whereas immunomodulatory and immunosuppressive agents such as colchicine, azathioprine, cyclosporine‐A, interferon‐alpha, and cyclophosphamide are used as steroid‐sparing agents and to prevent relapses. For aggressive, refractory or frequently relapsing cases, tumor necrosis factor (TNF) alpha inhibitors (infliximab, adalimumab, etanercept) have been reported beneficial. Herein, we describe our experience of 7 patients treated with TNF‐alpha inhibitors with recommendations regarding treatment choice during the COVID‐19 era. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Could co-infection with Anaplasma play a role in Borrelia-associated primary cutaneous marginal zone B-cell lymphomas?
- Author
-
Bonin, Serena, Stinco, Giuseppe, Patriarca, Maria, Trevisini, Sara, Di Meo, Nicola, and Trevisan, Giusto
- Subjects
Borrelia burgdorferi -- Case studies -- Health aspects ,Anaplasmosis -- Case studies -- Complications and side effects -- Development and progression -- Health aspects ,Lymphomas -- Case studies -- Development and progression -- Complications and side effects -- Health aspects - Abstract
Byline: Serena. Bonin, Giuseppe. Stinco, Maria. Patriarca, Sara. Trevisini, Nicola. di Meo, Giusto. Trevisan Sir, Borrelia burgdorferi , the causative agent of Lyme disease, infects humans through Ixodes tick bites. [...]
- Published
- 2016
17. Aggressive epidermotropic cutaneous CD8+ lymphoma
- Author
-
DI MEO, NICOLA, STINCO, GIUSEPPE, TREVISINI, SARA, TREVISAN, GIUSTO, Croatto, Margherita, DI MEO, Nicola, Stinco, Giuseppe, Trevisini, Sara, Croatto, Margherita, and Trevisan, Giusto
- Subjects
Male ,Skin Neoplasms ,skin cancer ,Humans ,cutaneous lymphoma ,CD8-Positive T-Lymphocytes ,Middle Aged ,cd8+ ,Lymphoma, T-Cell, Cutaneous - Abstract
none
- Published
- 2016
18. Acute localized exanthematous pustulosis caused by flurbiprofen
- Author
-
DI MEO, Nicola, Stinco, Giuseppe, Patrone, Pasquale, Trevisini, Sara, Trevisan, Giusto, DI MEO, Nicola, Stinco, Giuseppe, Patrone, Pasquale, Trevisini, Sara, and Trevisan, Giusto
- Subjects
Adult ,Acute Generalized Exanthematous Pustulosis ,Anti-Inflammatory Agents, Non-Steroidal ,Facial Dermatoses ,Female ,Flurbiprofen ,Humans ,Medicine (all) ,Anti-Inflammatory Agents ,Facial Dermatose ,Acute Generalized Exanthematous Pustulosi ,Non-Steroidal ,2708 - Abstract
N/A
- Published
- 2016
19. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study
- Author
-
A, Costanzo, L, Bianchi, M L, Flori, G, Malara, L, Stingeni, M, Bartezaghi, L, Carraro, G, Castellino, Bottoni, Ugo, Brazzelli, Valeria, Burlando, Martina, Cantoresi, Franca, Capo, Alessandra, Cattaneo, Angelo, Cusano, Francesco, Dapavo, Paolo, Del Giglio, Micol, Di Lernia, Vito, Di Nuzzo, Sergio, Dusi, Daniele, Concetta Fargnoli, Maria, Franchi, Chiara, Galluzzo, Marco, Ghilardi, Alberto, Hansel, Katharina, Loconsole, Francesco, Lora, Viviana, Malagoli, Piergiorgio, Mastrandrea, Valentina, Raffaele Mercuri, Santo, Letizia Musumeci, Maria, Naldi, Luigi, Narcisi, Alessandra, Offidani, Annamaria, Pagnanelli, Gianluca, Papini, Manuela, Patrizi, Annalisa, Pau, Monica, Pellacani, Giovanni, Peris, Ketty, Persechino, Severino, Piaserico, Stefano, Pietroleonardo, Lucia, Prignano, Francesca, Reseghetti, Alberto, Romanelli, Marco, Russo, Filomena, Sirna, Riccardo, Skroza, Nevena, Stinco, Giuseppe, Trevisini, Sara, Zane, Cristina, Zichichi, Leonardo, Zini, Antonio, Megna, Matteo, Ketty Peris (ORCID:0000-0002-5237-0463), A, Costanzo, L, Bianchi, M L, Flori, G, Malara, L, Stingeni, M, Bartezaghi, L, Carraro, G, Castellino, Bottoni, Ugo, Brazzelli, Valeria, Burlando, Martina, Cantoresi, Franca, Capo, Alessandra, Cattaneo, Angelo, Cusano, Francesco, Dapavo, Paolo, Del Giglio, Micol, Di Lernia, Vito, Di Nuzzo, Sergio, Dusi, Daniele, Concetta Fargnoli, Maria, Franchi, Chiara, Galluzzo, Marco, Ghilardi, Alberto, Hansel, Katharina, Loconsole, Francesco, Lora, Viviana, Malagoli, Piergiorgio, Mastrandrea, Valentina, Raffaele Mercuri, Santo, Letizia Musumeci, Maria, Naldi, Luigi, Narcisi, Alessandra, Offidani, Annamaria, Pagnanelli, Gianluca, Papini, Manuela, Patrizi, Annalisa, Pau, Monica, Pellacani, Giovanni, Peris, Ketty, Persechino, Severino, Piaserico, Stefano, Pietroleonardo, Lucia, Prignano, Francesca, Reseghetti, Alberto, Romanelli, Marco, Russo, Filomena, Sirna, Riccardo, Skroza, Nevena, Stinco, Giuseppe, Trevisini, Sara, Zane, Cristina, Zichichi, Leonardo, Zini, Antonio, Megna, Matteo, and Ketty Peris (ORCID:0000-0002-5237-0463)
- Published
- 2018
20. Adamantiades-Behçet disease at the beginning of the silk route: North-East Italian experience
- Author
-
Bergamo, Serena, di Meo, Nicola, Stinco, Giuseppe, Bonin, Serena, Trevisini, Sara, and Trevisan, Giusto
- Subjects
Infectious Diseases - Published
- 2017
21. A transient cutaneous relapse of AML M1 in hematological remission: a case report
- Author
-
di Meo, Nicola, Leonardo, Eugenio, Pozzato, Gabriele, Trevisan, Giusto, and Trevisini, Sara
- Published
- 2017
22. Living with chronic spontaneous urticaria in Italy: A narrative medicine project to improve the pathway of patient care
- Author
-
Cappuccio, Antonietta, Limonta, Tommaso, Parodi, Aurora, Cristaudo, Antonio, Bugliaro, Filomena, Cannavò, Serafinella P., Rossi, Oliviero, Gurioli, Carlotta, Vignoli, Alice, Parente, Roberta, Iemoli, Enrico, Caldarola, Giacomo, De Pità, Ornella, Di Nuzzo, Sergio, Cancian, Mauro, Potenza, Concetta, Caminati, Marco, Stingeni, Luca, Saraceno, Rosita, Trevisini, Sara, Piccirillo, Angelo, Sciarrone, Claudio, Panebianco, Rosanna, Gola, Massimo, Costanzo, Antonio, Grieco, Teresa, Massaroni, Katia, Reale, Luigi, Marini, Maria G., Caldarola, Giacomo (ORCID:0000-0002-8837-9232), Cappuccio, Antonietta, Limonta, Tommaso, Parodi, Aurora, Cristaudo, Antonio, Bugliaro, Filomena, Cannavò, Serafinella P., Rossi, Oliviero, Gurioli, Carlotta, Vignoli, Alice, Parente, Roberta, Iemoli, Enrico, Caldarola, Giacomo, De Pità, Ornella, Di Nuzzo, Sergio, Cancian, Mauro, Potenza, Concetta, Caminati, Marco, Stingeni, Luca, Saraceno, Rosita, Trevisini, Sara, Piccirillo, Angelo, Sciarrone, Claudio, Panebianco, Rosanna, Gola, Massimo, Costanzo, Antonio, Grieco, Teresa, Massaroni, Katia, Reale, Luigi, Marini, Maria G., and Caldarola, Giacomo (ORCID:0000-0002-8837-9232)
- Abstract
Chronic spontaneous urticaria (CSU) is perceived as a difficult to manage disease with negative impact on quality of life. The aim of this study was to highlight how to improve the care of people with CSU, using the methodology of narrative medicine. From June 2014 to March 2015, CSU-diagnosed patients and their physicians were asked to record their experiences of the condition in writing. Fourteen healthcare teams participated: 41% considered CSU as a challenge to overcome, while 22% experienced CSU as a big commitment. The number of professional involved was evaluated as insufficient in 11 hospitals. Seventy-five percent of the 190 Italian patients had visited 3 or more physicians before receiving a final diagnosis, with a perceived waste of time and resources. The therapeutic pathways were described as unsatisfactory in 83% of cases. As a result, anger and frustration were life-dominant emotions in 92% of patients. The critical points of the care pathway are related to organizational issues and lack of awareness.
- Published
- 2017
23. Pyoderma gangrenosum and burns: a special pathergy phenomenon
- Author
-
Di Meo, Nicola, primary, Stinco, Giuseppe, additional, Trevisini, Sara, additional, Damiani, Giovanni, additional, Giacomazzi, Donatella, additional, Luzzati, Roberto, additional, and Trevisan, Giusto, additional
- Published
- 2017
- Full Text
- View/download PDF
24. A transient cutaneous relapse of AML M1 in hematological remission: a case report
- Author
-
di Meo, Nicola, primary, Pozzato, Gabriele, additional, Leonardo, Eugenio, additional, Trevisini, Sara, additional, Vichi, Silvia, additional, and Trevisan, Giusto, additional
- Published
- 2017
- Full Text
- View/download PDF
25. Interobserver agreement on dermoscopic features of small basal cell carcinoma (<5 mm) among low-experience dermoscopists
- Author
-
di Meo, Nicola, primary, Damiani, Giovanni, additional, Vichi, Silvia, additional, Fadel, Mattia, additional, Nan, Katiuscia, additional, Noal, Cecilia, additional, Trevisini, Sara, additional, and Trevisan, Giusto, additional
- Published
- 2016
- Full Text
- View/download PDF
26. Lyme Borreliosis
- Author
-
Trevisan, Giusto, primary, Trevisini, Sara, additional, and di Meo, Nicola, additional
- Published
- 2016
- Full Text
- View/download PDF
27. Polypoid and fungating form of elephantiasic pretibial myxedema with involvement of the hands
- Author
-
di Meo, Nicola, primary, Nan, Katiuscia, additional, Noal, Cecilia, additional, Trevisini, Sara, additional, Fadel, Mattia, additional, Damiani, Giovanni, additional, Vichi, Silvia, additional, and Trevisan, Giusto, additional
- Published
- 2016
- Full Text
- View/download PDF
28. CASH algorithm versus 3-point checklist and its modified version in evaluation of melanocytic pigmented skin lesions: The 4-point checklist
- Author
-
di Meo, Nicola, primary, Stinco, Giuseppe, additional, Bonin, Serena, additional, Gatti, Alessandro, additional, Trevisini, Sara, additional, Damiani, Giovanni, additional, Vichi, Silvia, additional, and Trevisan, Giusto, additional
- Published
- 2015
- Full Text
- View/download PDF
29. CASH algorithm versus 3-point checklist and its modified version in evaluation of melanocytic pigmented skin lesions: The 4-point checklist.
- Author
-
Meo, Nicola, Stinco, Giuseppe, Bonin, Serena, Gatti, Alessandro, Trevisini, Sara, Damiani, Giovanni, Vichi, Silvia, and Trevisan, Giusto
- Abstract
Dermoscopy, in expert hands, increases accuracy, sensitivity and specificity in diagnosis of pigmented skin lesions of a single operator, compared with clinical examination. Simplified algorithmic methods have been developed to help less expert dermoscopists in diagnosis of melanocytic lesions. This study included 125 melanocytic skin lesions divided into melanocytic nevi, dysplastic nevi and thin melanomas (<1 mm). We compared the 3-point checklist and CASH algorithm to analyze different pigmented skin lesions. Based on preliminary results, we proposed a new modified algorithm, called the 4-point checklist, whose accuracy is similar to the CASH algorithm and whose simplicity is similar to the 3-point checklist. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
30. Interobserver agreement on dermoscopic features of small basal cell carcinoma (<5 mm) among low-experience dermoscopists.
- Author
-
Meo, Nicola, Damiani, Giovanni, Vichi, Silvia, Fadel, Mattia, Nan, Katiuscia, Noal, Cecilia, Trevisini, Sara, and Trevisan, Giusto
- Abstract
The basal cell carcinoma ( BCC) assessment in dermoscopy is based on the recognition of specific characteristics synthesized and described as classical and non-classical criteria, but which may not necessarily present all at the same time. Consequently, a deep knowledge in detecting the aforementioned dermoscopic criteria is crucial in diagnosis. The aim of the study was to evaluate which criteria are more frequently recognized among a group of low-experienced dermoscopists when confronted with the difficult diagnosis of BCC with a diameter lower than 5 mm. We examined 100 BCC finding that data displays a full agreement only for one classical criterion, the lack of pigmented network (Fleiss' κ = 1), while among other classical criteria only arborizing vessels and ulceration exhibit a good agreement among observers (Fleiss' κ > 0.40). Analyzing non-classical criteria, only blue-whitish veil and blue in-focus dots show a good agreement among low-experience observers (Fleiss' κ > 0.40). It is evident that in small size BCC classic dermoscopic criteria are often substituted by non-classical criteria, which represent the neoplasm's early phase. Thus, it is of importance, especially for low-experience dermoscopists, to analyze even the non-classical criteria in order to obtain a diagnosis of early BCC. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
31. Monolateral Grover's Disease with Blaschkoid Distribution.
- Author
-
di Meo, Nicola, Ulessi, Bruno, Trevisini, Sara, Noal, Cecilia, Nan, Katiuscia, Vichi, Silvia, and Trevisan, Giusto
- Published
- 2017
32. Polypoid and fungating form of elephantiasic pretibial myxedema with involvement of the hands.
- Author
-
Meo, Nicola, Nan, Katiuscia, Noal, Cecilia, Trevisini, Sara, Fadel, Mattia, Damiani, Giovanni, Vichi, Silvia, and Trevisan, Giusto
- Subjects
MYXEDEMA ,HYPOTHYROIDISM - Abstract
A letter to the editor in response to the article " Polypoid and fungating form of elephantiasic pretibial myxedema with involvement of the hands," that was published in a previous issue of the journal is presented.
- Published
- 2016
- Full Text
- View/download PDF
33. Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise Analysis of the SUPREME Study
- Author
-
Luca Stingeni, Giovanna Malara, Andrea Conti, Luisa Di Costanzo, Carlo Giovanni Carrera, Martina Burlando, Piergiorgio Malagoli, Maria Letizia Musumeci, Federico Bardazzi, Valeria Brazzelli, Paolo Amerio, Clara De Simone, Sara Trevisini, Anna Balato, Matteo Megna, Francesco Loconsole, Catia De Felice, Marta Bartezaghi, Alice Rausa, Elisabetta Aloisi, Roberto Orsenigo, Antonio Costanzo, Stingeni, Luca, Malara, Giovanna, Conti, Andrea, Di Costanzo, Luisa, Carrera, Carlo Giovanni, Burlando, Martina, Malagoli, Piergiorgio, Musumeci, Maria Letizia, Bardazzi, Federico, Brazzelli, Valeria, Amerio, Paolo, De Simone, Clara, Trevisini, Sara, Balato, Anna, Megna, Matteo, Loconsole, Francesco, De Felice, Catia, Bartezaghi, Marta, Rausa, Alice, Aloisi, Elisabetta, Orsenigo, Roberto, and Costanzo, Antonio
- Subjects
Hospital Anxiety and Depression Scale ,Clinical, Cosmetic and Investigational Dermatology ,patient-reported outcomes ,Dermatology Quality of Life Index ,PASI ,Dermatology ,patient-reported outcome ,plaque psoriasis - Abstract
Luca Stingeni,1 Giovanna Malara,2,3 Andrea Conti,4 Luisa Di Costanzo,5 Carlo Giovanni Carrera,6 Martina Burlando,7 Piergiorgio Malagoli,8 Maria Letizia Musumeci,9 Federico Bardazzi,10 Valeria Brazzelli,11 Paolo Amerio,12 Clara De Simone,13,14 Sara Trevisini,15 Anna Balato,16 Matteo Megna,17 Francesco Loconsole,18 Catia De Felice,19 Marta Bartezaghi,20 Alice Rausa,20 Elisabetta Aloisi,20 Roberto Orsenigo,20 Antonio Costanzo21,22 On behalf of the SUPREME Study Group1Dermatology Section, Medical and Surgical Department, University of Perugia, Perugia, Italy; 2Dermatology Unit, Hospital âBianchi Melacrino Morelliâ, Reggio Calabria, Italy; 3Department of Dermatology, Papardo Hospital, Messina, Italy; 4Dermatologic Unit, Department of Surgery, Infermi Hospital, AUSL Romagna, Rimini, Italy; 5Department of Dermatology, âGaetano Rummoâ Hospital, Benevento UOC Dermatologia, AO G. Rummo, Benevento, Italy; 6U.O. Dermatologia, Fondazione IRCCS Caâ Granda - Ospedale Maggiore Policlinico, Milano, Italy; 7IRCCS San Martino Polyclinic Hospital, Di.S.Sal. Section of Dermatology, Genoa, Italy; 8Dermatology Unit IRCCS Policlinico San Donato, Milan, Italy; 9Dermatology Clinic, University of Catania, Catania, Italy; 10Division of Dermatology, University Hospital Policlinico âS. Orsola-Malpighiâ, Bologna, Italy; 11Institute of Dermatology, Foundation IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy; 12Dermatologic Clinic, G. DâAnnunzio University, Chieti, Italy; 13Istituto di Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy; 14Fondazione Policlinico Universitario A. Gemelli â IRCCS, Rome, Italy; 15Dermatology Department, University of Trieste, Trieste, Italy; 16Dermatology Unit, University of Campania âLuigi Vanvitelliâ, Naples, Italy; 17Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 18Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy; 19Department of Clinical Dermatology, Centre for the Study and Treatment of Psoriasis, San Gallicano Dermatological Institute, IRCCS, Rome, Italy; 20Novartis Farma SpA, Origgio, Italy; 21Unit of Dermatology, IRCCS Humanitas Research Hospital, Milan, Italy; 22Department of Biomedical Sciences, Humanitas University, Milan, ItalyCorrespondence: Luca Stingeni, Dermatology Section, Medical and Surgical Department, University of Perugia, Perugia, Italy, Tel +39075-5783881, Email luca.stingeni@unipg.itPurpose: Psoriasis, a common systemic inflammatory disorder, presents with gender-related differences in the quality of life (QoL) and treatment outcomes. This post hoc analysis from the Phase 3b SUPREME study explored gender-related differences in patient characteristics and efficacy of secukinumab 300 mg on Psoriasis Area and Severity Index (PASI) 75/90/100 and impact on QoL using the Dermatology Life Quality Index (DLQI) in patients with moderate to severe psoriasis through week 24.Patients and Methods: The proportion of patients achieving PASI 75/90/100 was computed using a nonresponder imputation approach. Differences between cohorts were analyzed using a logistic regression model. The mean change from baseline in DLQI was computed using the Wilcoxon test.Results: Among the 433 patients (males: 71.6%), females had a higher DLQI than males at baseline (13.1 vs 9.5; P< 0.0001). Males had a slightly higher response for PASI 90 than females at week 16 (80.7% vs 78.1%; P=0.0779) and 24 (83.2% vs 79.7%; P=0.0319). No differences were observed between genders in PASI 100/75 responses at week 24. Both genders showed an improvement in DLQI with secukinumab at week 24 (â 10.9 vs â 8.1, respectively, in females vs males; P=0.0004).Conclusion: In summary, secukinumab was effective in the treatment of psoriasis, irrespective of gender.Keywords: plaque psoriasis, PASI, patient-reported outcomes, Dermatology Quality of Life Index, Hospital Anxiety and Depression Scale
- Published
- 2023
34. Adamantiades-Behçet's disease therapy: current treatment options and recommendations with regard to the COVID-19 pandemic
- Author
-
Sara Trevisini, Giusto Trevisan, Iris Zalaudek, Serena Bonin, Trevisini, Sara, Trevisan, Giusto, Zalaudek, Iri, and Bonin, Serena
- Subjects
therapy ,TNF alpha inhibitor ,Adamantiades-Behçet's disease ,COVID ,TNF alpha inhibitors ,SARS-CoV-2 ,Behcet Syndrome ,Dermatology ,General Medicine ,Etanercept ,COVID-19 Drug Treatment ,Humans ,Pandemics - Abstract
Adamantiades-Behçet's disease (ABD) is a chronic, idiopathic, relapsing immune-mediate disease that may involve multiple organs. It is characterized by recurrent oral and genital ulcers, skin lesions, ocular, gastrointestinal, vascular, neurological and joint involvement. It can lead to significant morbidity and mortality. Due to its heterogeneity in clinical findings and physiopathology, its treatment can be various as ABD manifestations in different organs may differently respond to the same drug. The cornerstone of therapy for inducing remission is systemic corticosteroid, whereas immunomodulatory and immunosuppressive agents such as colchicine, azathioprine, cyclosporine-A, interferon-alpha, and cyclophosphamide are used as steroid-sparing agents and to prevent relapses. For aggressive, refractory or frequently relapsing cases, tumor necrosis factor (TNF) alpha inhibitors (infliximab, adalimumab, etanercept) have been reported beneficial. Herein, we describe our experience of 7 patients treated with TNF-alpha inhibitors with recommendations regarding treatment choice during the COVID-19 era.
- Published
- 2021
35. Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis. SUPREME study
- Author
-
Costanzo, A., Bianchi, L., Flori, M. L., Malara, G., Stingeni, L., Bartezaghi, M., Carraro, L., Castellino, G., Bottoni, U, Brazzelli, V, Burlando, M, Cantoresi, F, Capo, A, Cattaneo, A, Cusano, F, Dapavo, P, Del Giglio, M, Di Lernia, V, Di Nuzzo, S, Dusi, D, Fargnoli, Mc, Franchi, C, Galluzzo, M, Ghilardi, A, Hansel, K, Loconsole, F, Lora, V, Malagoli, P, Mastrandrea, V, Megna, M, Mercuri, Sr, Letizia Musumeci, M, Naldi, L, Narcisi, A, Offidani, A, Pagnanelli, G, Papini, M, Patrizi, A, Pau, M, Pellacani, G, Peris, K, Persechino, S, Piaserico, S, Pietroleonardo, L, Prignano, F, Reseghetti, A, Romanelli, M, Russo, F, Sirna, R, Skroza, N, Stinco, G, Trevisini, S, Zane, C, Zichichi, L, Zini, A., Costanzo, A., Bianchi, L., Flori, M. L., Malara, G., Stingeni, L., Bartezaghi, M., Carraro, L., Castellino, G., Persechino, Severino, Pau, Monica, Cusano, Francesco, Russo, Filomena, Stinco, Giuseppe, Ghilardi, Alberto, Del Giglio, Micol, De Luca, Giuseppe, Brazzelli, Valeria, Fargnoli, Maria Concetta, Capo, Alessandra, Mastrandrea, Valentina, Piaserico, Stefano, Franchi, Chiara, Zane, Cristina, Cattaneo, Angelo, Galluzzo, Marco, La Selva, Roberta, Di Nuzzo, Sergio, Megna, Matteo, Pellacani, Giovanni, Peris, Ketty, Patrizi, Annalisa, Trevisini, Sara, Pagnanelli, Gianluca, Skroza, Nevena, Malagoli, Piergiorgio, Resghetti, Alberto, Burlando, Martina, Loconsole, Francesco, Offidani, Anna Maria, Albertini, Giuseppe, Mercuri, Santo Raffaele, Bottoni, Ugo, Dusi, Daniele, Zini, Antonio, Pietroleonardo, Lucia, Cantoresi, Franca, Sirna, Riccardo, Lora, Viviana, Hansel, Katharina, Prignano, Francesca, and Natalini, Ylenia
- Subjects
Adult ,Male ,medicine.medical_specialty ,Psoriasis, secukinumab ,Genotyping Techniques ,Dermatology ,HLA-C Antigens ,Antibodies, Monoclonal, Humanized ,Severity of Illness Index ,Antibodies ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Antibodies, Monoclonal ,Biomarkers ,Female ,Genetic Predisposition to Disease ,Humans ,Interleukin-17 ,Italy ,Middle Aged ,Prospective Studies ,Psoriasis ,Treatment Outcome ,0302 clinical medicine ,Internal medicine ,Severity of illness ,Monoclonal ,medicine ,Clinical endpoint ,Adverse effect ,Prospective cohort study ,Humanized ,Settore MED/35 - Malattie Cutanee e Veneree ,business.industry ,medicine.disease ,Confidence interval ,030220 oncology & carcinogenesis ,Secukinumab ,Interleukin 17 ,business - Abstract
Background Understanding genetic variations is important in predicting treatment response and forms the basis for identifying new pharmacogenetic and pharmacogenomic targets for psoriasis treatment. There are limited data on the efficacy of secukinumab in relation to genetic markers. Objectives To evaluate the efficacy and safety of secukinumab 300 mg in HLA-Cw6-positive (Cw6-POS) and HLA-Cw6-negative (Cw6-NEG) patients with moderate-to-severe chronic plaque-type psoriasis. Methods SUPREME was a 24-week, phase IIIb study with an extension period up to 72 weeks. Primary end point was Psoriasis Area Severity Index (PASI) 90 response rate after 16 weeks. Results In total, 434 patients were recruited: 185 (42·6%) were Cw6-POS and 246 (56·7%) were Cw6-NEG (three not assessed). Mean ± SD age was 45·2 ± 13·2 years (Cw6-POS 42·7 ± 13·1; Cw6-NEG 47·2 ± 12·9). The baseline PASI score was comparable between the cohorts [Cw6-POS 20·7 ± 8·99; Cw6-NEG 21·5 ± 9·99 (P = 0·777)]. At week 16, PASI 90 was achieved in 80·4% of Cw6-POS and 79·7% of Cw6-NEG patients (difference 0·76; 95% confidence interval -7·04 to 8·23). No differences in absolute PASI at week 16 (Cw6-POS 1·36 ± 3·58; Cw6-NEG 1·18 ± 2·29) were observed. The overall safety profile of secukinumab was consistent with that previously reported. No statistically significant difference was detected in the rate of treatment-emergent adverse events [Cw6-POS 42·7%; Cw6-NEG 49·6% (P = 0·295)]. A high PASI 90 response was achieved with secukinumab with a fast reduction in absolute PASI. Conclusions Determination of HLA-Cw6 status for secukinumab therapy is unnecessary, as it is highly effective regardless of HLA-Cw6 status.
- Published
- 2018
36. Polypoid and fungating form of elephantiasic pretibial myxedema with involvement of the hands
- Author
-
Nicola di Meo, Giusto Trevisan, Mattia Fadel, Giovanni Damiani, Katiuscia Nan, Sara Trevisini, Silvia Vichi, Cecilia Noal, DI MEO, Nicola, Nan, Katiuscia, Noal, Cecilia, Trevisini, Sara, Fadel, Mattia, Damiani, Giovanni, Vichi, Silvia, and Trevisan, Giusto
- Subjects
medicine.medical_specialty ,Leg Dermatosis ,Hand Dermatose ,Graves' disease ,Hand Dermatoses ,Dermatology ,Leg Dermatoses ,Elephantiasic pretibial myxedema ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Hand Dermatosis ,Myxedema ,medicine ,Humans ,business.industry ,Middle Aged ,medicine.disease ,Graves Disease ,Surgery ,Leg Dermatose ,030220 oncology & carcinogenesis ,Female ,2708 ,business ,Human - Abstract
NONE
- Published
- 2016
37. Pyoderma gangrenosum and burns: A special pathergy phenomenon
- Author
-
Giusto Trevisan, Nicola di Meo, Sara Trevisini, Giovanni Damiani, Roberto Luzzati, Donatella Giacomazzi, Giuseppe Stinco, DI MEO, Nicola, Stinco, Giuseppe, Trevisini, Sara, Damiani, Giovanni, Giacomazzi, Donatella, Luzzati, Roberto, and Trevisan, Giusto
- Subjects
medicine.medical_specialty ,pyoderma gangrenous ,burns ,pathergy ,business.industry ,Medicine (all) ,Dermatology ,medicine.disease ,Infectious Diseases ,pyoderma gangrenou ,medicine ,Pathergy ,burn ,business ,Pyoderma gangrenosum ,2708 - Abstract
N/A
- Published
- 2017
38. Lyme borreliosis
- Author
-
Giusto Trevisan, Sara Trevisini, Nicola di Meo, Trevisan, Giusto, Trevisini, Sara, and DI MEO, Nicola
- Subjects
Dermatology ,lyme ,bacterial infections and mycoses ,borreliosis - Abstract
N/A
- Published
- 2016
39. Could co-infection with anaplasma play a role in borrelia-associated Primary Cutaneous Marginal Zone B-Cell Lymphomas?
- Author
-
Sara Trevisini, Giusto Trevisan, Maria Martina Patriarca, Nicola di Meo, Giuseppe Stinco, Serena Bonin, Bonin, Serena, Stinco, Giuseppe, Patriarca, Mm, Trevisini, Sara, DI MEO, Nicola, and Trevisan, Giusto
- Subjects
Male ,Anaplasmosis ,Skin Neoplasms ,Lymphoma ,Biopsy ,Marginal Zone ,030207 dermatology & venereal diseases ,0302 clinical medicine ,Recurrence ,Marginal zone B-cell ,lcsh:Dermatology ,Needle ,Lyme disease ,primary cutaneous B-cell lymphoma ,biology ,Coinfection ,Biopsy, Needle ,Middle Aged ,Immunohistochemistry ,medicine.anatomical_structure ,Infectious Diseases ,030220 oncology & carcinogenesis ,Doxycycline ,Female ,Borrelia Infections ,Anaplasma phagocytophilum ,Adult ,Anaplasma ,Dermatology ,Borrelia burgdorferi ,Rickettsia helvetica ,Risk Assessment ,Sampling Studies ,03 medical and health sciences ,Borrelia ,medicine ,Humans ,B cell ,business.industry ,B-Cell ,Lymphoma, B-Cell, Marginal Zone ,lcsh:RL1-803 ,medicine.disease ,biology.organism_classification ,bacterial infections and mycoses ,Follow-Up Studies ,2708 ,Immunology ,bacteria ,business - Abstract
Background: Borrelia burgdorferi has been associated with primary cutaneous B-cell lymphoma, in particular with cutaneous marginal zone B cell lymphoma. Ixodes ticks, which are vectors of Borrelia burgdorferi, can also transmit many other microorganisms such as Anaplasma phagocytophilum and Rickettsia helvetica. Nowadays data on the frequency of these co-infections are still conflicting, but in our geographical area (north-eastern of Italy) they appear rather frequently. Aim: To investigate the presence of co-infections with Anaplasma phagocytophilum and Rickettsia helvetica, in patients with proven Borrelia burgdorferi-related cutaneous marginal zone B cell lymphoma. Methods: Four consecutive patients with a histopathological diagnosis of cutaneous marginal zone B cell lymphoma were investigated for the presence of Borrelia burgdorferi with conventional serology and with PCR, and for the presence of Anaplasma phagocytophilum and Rickettsia helvetica with conventional serology. Results: Serologic test for Borrelia burgdorferi was positive in 2 cases, while PCR assays for Borrelia burgdorferi performed on DNA from the biopsy and peripheral blood was positive in all four patients. Serologic analysis for Rickettsia helvetica was positive in one patient, while serologic analysis for Anaplasma phagocytophilum was positive in all patients. Conclusions: Our case series have revealed a co-infection between Borrelia burgdorferi and Anaplasma phagocytophilum in all patients with cutaneous marginal zone B cell lymphoma. Therefore more comprehensive analyses on the co-existence of Anaplasma phagocytophilum infection should be performed in patients with Borrelia burgdorferi-related cutaneous marginal zone B cell lymphoma.
- Published
- 2016
40. Interobserver agreement on dermoscopic features of small basal cell carcinoma (<5 mm) among low-experience dermoscopists
- Author
-
Sara Trevisini, Silvia Vichi, Nicola di Meo, Giusto Trevisan, Cecilia Noal, Giovanni Damiani, Mattia Fadel, Katiuscia Nan, DI MEO, Nicola, Damiani, Giovanni, Vichi, Silvia, Fadel, Mattia, Nan, Katiuscia, Noal, Cecilia, Trevisini, Sara, and Trevisan, Giusto
- Subjects
basal cell carcinomas ,Male ,medicine.medical_specialty ,Pathology ,Skin Neoplasms ,Basal Cell ,Dermoscopy ,Dermatology ,Biology ,classical criteria ,consensus agreement ,dermoscopy ,low experience ,Aged ,Carcinoma, Basal Cell ,Early Detection of Cancer ,Female ,Humans ,Observer Variation ,Random Allocation ,2708 ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,basal cell carcinoma ,medicine ,Deep knowledge ,Basal cell carcinoma ,Skin Neoplasm ,Random allocation ,Carcinoma ,General Medicine ,medicine.disease ,030220 oncology & carcinogenesis ,Radiology ,Early phase ,Observer variation ,Human - Abstract
The basal cell carcinoma (BCC) assessment in dermoscopy is based on the recognition of specific characteristics synthesized and described as classical and non-classical criteria, but which may not necessarily present all at the same time. Consequently, a deep knowledge in detecting the aforementioned dermoscopic criteria is crucial in diagnosis. The aim of the study was to evaluate which criteria are more frequently recognized among a group of low-experienced dermoscopists when confronted with the difficult diagnosis of BCC with a diameter lower than 5 mm. We examined 100 BCC finding that data displays a full agreement only for one classical criterion, the lack of pigmented network (Fleiss' κ = 1), while among other classical criteria only arborizing vessels and ulceration exhibit a good agreement among observers (Fleiss' κ > 0.40). Analyzing non-classical criteria, only blue-whitish veil and blue in-focus dots show a good agreement among low-experience observers (Fleiss' κ > 0.40). It is evident that in small size BCC classic dermoscopic criteria are often substituted by non-classical criteria, which represent the neoplasm's early phase. Thus, it is of importance, especially for low-experience dermoscopists, to analyze even the non-classical criteria in order to obtain a diagnosis of early BCC. © 2016 Japanese Dermatological Association
- Published
- 2016
41. CASH algorithm versus 3-point checklist and its modified version in evaluation of melanocytic pigmented skin lesions: Thee 4 point checklist
- Author
-
Giovanni Damiani, Giuseppe Stinco, Sara Trevisini, Silvia Vichi, Nicola di Meo, Alessandro Gatti, Giusto Trevisan, Serena Bonin, DI MEO, Nicola, Stinco, Giuseppe, Bonin, Serena, Gatti, Alessandro, Trevisini, Sara, Damiani, Giovanni, Vichi, Silvia, and Trevisan, Giusto
- Subjects
0301 basic medicine ,Skin Neoplasms ,melanocytic nevu ,Physical examination ,Dermatology ,3-point checklist ,CASH ,dermoscopy ,melanocytic nevus ,melanoma ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Nevus, Pigmented ,integumentary system ,medicine.diagnostic_test ,business.industry ,Melanoma ,General Medicine ,Melanocytic nevus ,medicine.disease ,Checklist ,030104 developmental biology ,Pigmented skin ,business ,Skin lesion ,Algorithm ,Algorithms - Abstract
Dermoscopy, in expert hands, increases accuracy, sensitivity and specificity in diagnosis of pigmented skin lesions of a single operator, compared with clinical examination. Simplified algorithmic methods have been developed to help less expert dermoscopists in diagnosis of melanocytic lesions. This study included 125 melanocytic skin lesions divided into melanocytic nevi, dysplastic nevi and thin melanomas (
- Published
- 2016
42. Abdominopelvic post-irradiation morphea in a prostate cancer patient: the first case of an under-recognized condition
- Author
-
Giusto Trevisan, di Meo N, Cecilia Noal, Bruno Ulessi, Sara Trevisini, DI MEO, Nicola, Noal, Cecilia, Trevisini, Sara, Ulessi, B., and Trevisan, Giusto
- Subjects
medicine.medical_specialty ,business.industry ,General surgery ,Dermatology ,MORPHEA ,PROSTATE CANCER ,Thigh ,medicine.disease ,Prostate cancer ,Infectious Diseases ,medicine.anatomical_structure ,Text mining ,medicine ,Abdomen ,Radiodermatitis ,Radiology ,Differential diagnosis ,business ,Pelvis ,Morphea - Abstract
NONE
- Published
- 2015
43. Sporotrichoid Mycobacterium marinum infection in an elderly woman
- Author
-
Sara Trevisini, Giusto Trevisan, Nicola di Meo, Antonio Albano, Sergio Umberto De Marchi, Giuseppe Stinco, DI MEO, Nicola, Stinco, Giuseppe, Trevisini, Sara, DE MARCHI, SERGIO UMBERTO, Albano, Antonio, and Trevisan, Giusto
- Subjects
Mycobacterium marinum sporotrichoid nodules ,medicine.medical_specialty ,Mycobacterium Infections, Nontuberculous ,Dermatology ,Diagnosis, Differential ,Clarithromycin ,Mycobacterium marinum Infection ,medicine ,Animals ,Humans ,Mycobacterium marinum ,Skin ,Aged, 80 and over ,Distal forearm ,Doxycycline ,integumentary system ,biology ,business.industry ,Skin exposure ,Fishes ,General Medicine ,bacterial infections and mycoses ,biology.organism_classification ,Anti-Bacterial Agents ,Surgery ,Regimen ,Drug Therapy, Combination ,Female ,Rifampin ,business ,Rifampicin ,medicine.drug - Abstract
We describe the case of an elderly woman who acquired a Mycobacterium marinum infection following skin exposure to the bacteria through a small wound on her right ring finger, obtained while preparing fish. The resultant sporotrichoid nodules of the right hand and the distal forearm, refractory to the initial therapy with doxycycline and rifampicin, were successfully treated with oral regimen of clarithromycin.
- Published
- 2015
44. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
- Author
-
Bergamo S, di Meo N, Stinco G, Bonin S, Trevisini S, and Trevisan G
- Subjects
- Adult, Case-Control Studies, Female, Humans, Italy, Male, Middle Aged, Sensitivity and Specificity, Behcet Syndrome complications, Behcet Syndrome diagnosis
- Abstract
Dear Editor, Adamantiades-Behçet's disease (ABD) is an inflammatory disease classified as vasculitis, which was originally diagnosed in patients with aphthous stomatitis, genital ulcerations, and ocular manifestations. However, any organ or system may be involved, particularly the central and peripheral nervous systems, joints, as well as the gastrointestinal tract. The etiology of ABD is still not fully understood, but some evidence indicates that an autoimmune process could be triggered by an infectious or environmental agent specific for the geographic region (1). Although BD can occur worldwide, it is most prevalent in the region along the ancient commercial route called the "Silk Road". In Italy, studies on the precise prevalence of ABD are lacking (2). As there are no specific diagnostic laboratory tests or histopathologic findings which confirm the preliminary diagnosis, the final diagnosis should be based on clinical criteria (3). Skin and mucosae are the target organs of this disease, and therefore their involvement has been considered in the numerous diagnostic criteria developed over the years (4). The first most important and popular criteria were created in 1990 by the International Study Group (ISG) (5). Because of their low sensitivity, the new International Criteria for Behçet's Disease (ICBD) were established, and were presented at the International Conference of Behçet's Disease in Lisbon in 2006 (6,7). In 2014, the International Team for the Revision of the International Criteria for BD submitted new criteria assigning 2 points to ocular lesions, oral aphthosis, and genital aphthosis, and 1 point to skin lesions, central nervous system involvement, and vascular manifestations. The pathergy test, when used, was assigned 1 point. A patient scoring ≥4 points is classified as having BD (8). We performed a single center, case-control study on a cohort of patients of Friuli Venezia Giulia, enrolled from January 2010 to September 2015 in the Dermatology Unit of the University of Trieste. The aim was to analyze the clinical features and compare the sensitivity, specificity, and accuracy of the three diagnostic criteria for ABD presented above in patients born in this particular region which is located at the very start of the "Silk Route". We enrolled 153 consecutive patients (74 cases and 79 controls) in the study. The characteristics and clinical features of patients and controls are summarized in Table 1. The most common diagnoses in the control group were recurrent oral aphtosis, lichen planus, mucous-membrane pemphigoid, and lupus erythematosus. The inclusion criterion was the presence of at least one principal clinical feature of ABD (oral aphtosis, genital aphtosis, skin lesions, ocular involvement) properly recorded in clinical records. Patient recruitment was done in a consecutive manner. Exclusion criteria were incomplete clinical records and absence of follow-up data. The diagnosis of ABD was established by expert dermatologists, without the use of any particular diagnostic criterion. For ABD, diagnosis agreement among dermatologists was required. The study was conducted according to the Declaration of Helsinki protocols. Possible associations between categorical variables were detected by the use of Fisher's exact test or Pearson χ2 test, depending on the sample size. Logistic regression was performed in order to identify which symptoms are of higher impact in the diagnosis of ABD. A comparison in terms of sensitivity, specificity, and accuracy among the three diagnostic criteria (ISG 1990, ITR 2006, and ITR 2014) was performed. The receiver operator characteristic (ROC) curve was obtained for each diagnostic criterion. Data were produced with a 95% confidence interval; P values <0.05 were considered statistically significant. Statistical analysis was done using Stata SE12 software (Stata Corporation, Tx, USA). According to our data, patients with ABD had a significantly lower age at diagnosis compared with controls (P=0.0001); this was confirmed for both men (P=0.0006) and women (P=0.004). The presence of oral aphtosis was not necessarily pathognomonic of ABD (P=0.005) as it was found in 97.3% of patients with ABD and in 83.5% of controls. Genital aphtosis was directly associated with ABD diagnosis (P<0.001), as it was present in 79.7% of patients with ABD, but in only 8.9% of controls. Furthermore, even skin manifestations and ocular lesions were observed at different rates in patients with ABD and controls (P<0.001 and P=0.003, respectively). The presence of pseudofolliculitis was significantly more frequent in patients than in controls (P<0.001), whereas erythema nodosum and skin aphtosis did not differ considerably between ABD and controls. Joint manifestations were as common in patients with ABD as in controls (P=0.6): arthralgia and arthritis alone do not indicate a diagnosis of ABD. Neurological symptoms as well as vascular involvement, if present, can be suggestive of ABD, but their absence does not exclude an ABD diagnosis (P=0.06 and P=0.04). Positive pathergy tests and positive HLA B51 tests were significantly more frequent in patients than in controls (P=0.007 and P=0.009, respectively), although if negative they did not exclude a diagnosis of ABD. Logistic regression showed that genital aphtosis (odds ratio (OR)=12948, P<0.001), neurological manifestations (OR=819.263, P=0.001), vascular manifestations (OR=240.2573, P=0.001), cutaneous manifestations (OR=104.5625, P=0.002), oral aphtosis (OR=145.3229, P=0.004), and younger age at diagnosis (OR=0.8950334, P=0.000) were associated with ABD diagnosis (Table 2). There was no single pathognomonic symptom of ABD. We found that the ITR criteria -both from 2006 and 2014 - had a higher sensitivity (98.7% and 100%, respectively), specificity (94.9% and 97.9%, respectively), and accuracy (96.7% and 98.7%, respectively) compared with the ISG 1990 criterion, which scored 66% sensitivity, 100% specificity, and 83.7% accuracy. Area Under Roc Curve (AUC) was significantly different between ISG 1990 and ITR 2006 and between ISG 1990 and ITR 2014 (Figure 1). Even though no statistically significant difference was found between the ITR 2014 and ITR 2006 criteria, the former had a better performance according to our records. The clinical features reported in our retrospective case-control study are comparable to data found in the literature from European and international reports. A recent study (8) found a similar organ involvement percentage to our study, although we found a higher prevalence of HLA B51 positive patients and a lower percentage of ocular manifestations in our records. The results of the logistic regression performed based on our records indicate genital aphtosis, oral aphtosis, ocular involvement, neurological signs, and vascular features are more strongly linked to the diagnosis of ABD. According to our data, the presence of oral aphtosis is not paramount for the diagnosis of ABD, which fits well with the intent of the ITR 2006 and 2014 diagnostic criteria. The new ITR 2014 criteria added neurological signs to the diagnostic symptoms of ABD, emphasizing the importance of a multidisciplinary approach to patients suspected to have ABD.
- Published
- 2017
45. Pyoderma gangrenosum and burns: a special pathergy phenomenon.
- Author
-
DI Meo N, Stinco G, Trevisini S, Damiani G, Giacomazzi D, Luzzati R, and Trevisan G
- Subjects
- Burns complications, Humans, Male, Middle Aged, Pyoderma Gangrenosum etiology, Pyoderma Gangrenosum pathology, Burns therapy, Pyoderma Gangrenosum diagnosis
- Published
- 2017
- Full Text
- View/download PDF
46. Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care.
- Author
-
Cappuccio A, Limonta T, Parodi A, Cristaudo A, Bugliaro F, Cannavò SP, Rossi O, Gurioli C, Vignoli A, Parente R, Iemoli E, Caldarola G, De Pità O, Di Nuzzo S, Cancian M, Potenza C, Caminati M, Stingeni L, Saraceno R, Trevisini S, Piccirillo A, Sciarrone C, Panebianco R, Gola M, Costanzo A, Grieco T, Massaroni K, Reale L, and Marini MG
- Subjects
- Adult, Chronic Disease, Emotions, Female, Humans, Italy epidemiology, Male, Narration, Prevalence, Surveys and Questionnaires, Urticaria epidemiology, Quality of Life, Urticaria psychology, Urticaria therapy
- Abstract
Chronic spontaneous urticaria (CSU) is perceived as a difficult to manage disease with negative impact on quality of life. The aim of this study was to highlight how to improve the care of people with CSU, using the methodology of narrative medicine. From June 2014 to March 2015, CSU-diagnosed patients and their physicians were asked to record their experiences of the condition in writing. Fourteen healthcare teams participated: 41% considered CSU as a challenge to overcome, while 22% experienced CSU as a big commitment. The number of professional involved was evaluated as insufficient in 11 hospitals. Seventy-five percent of the 190 Italian patients had visited 3 or more physicians before receiving a final diagnosis, with a perceived waste of time and resources. The therapeutic pathways were described as unsatisfactory in 83% of cases. As a result, anger and frustration were life-dominant emotions in 92% of patients. The critical points of the care pathway are related to organizational issues and lack of awareness.
- Published
- 2017
- Full Text
- View/download PDF
47. Aggressive epidermotropic cutaneous CD8+ lymphoma.
- Author
-
DI Meo N, Stinco G, Trevisini S, Croatto M, and Trevisan G
- Subjects
- Humans, Lymphoma, T-Cell, Cutaneous pathology, Male, Middle Aged, Skin Neoplasms pathology, CD8-Positive T-Lymphocytes pathology, Lymphoma, T-Cell, Cutaneous diagnosis, Skin Neoplasms diagnosis
- Published
- 2016
48. Acute localized exanthematous pustulosis caused by flurbiprofen.
- Author
-
di Meo N, Stinco G, Patrone P, Trevisini S, and Trevisan G
- Subjects
- Acute Generalized Exanthematous Pustulosis pathology, Adult, Facial Dermatoses pathology, Female, Humans, Acute Generalized Exanthematous Pustulosis etiology, Anti-Inflammatory Agents, Non-Steroidal adverse effects, Facial Dermatoses chemically induced, Flurbiprofen adverse effects
- Published
- 2016
49. CASH algorithm versus 3-point checklist and its modified version in evaluation of melanocytic pigmented skin lesions: The 4-point checklist.
- Author
-
di Meo N, Stinco G, Bonin S, Gatti A, Trevisini S, Damiani G, Vichi S, and Trevisan G
- Subjects
- Algorithms, Checklist, Humans, Dermoscopy standards, Melanoma diagnosis, Nevus, Pigmented diagnosis, Skin Neoplasms diagnosis
- Abstract
Dermoscopy, in expert hands, increases accuracy, sensitivity and specificity in diagnosis of pigmented skin lesions of a single operator, compared with clinical examination. Simplified algorithmic methods have been developed to help less expert dermoscopists in diagnosis of melanocytic lesions. This study included 125 melanocytic skin lesions divided into melanocytic nevi, dysplastic nevi and thin melanomas (<1 mm). We compared the 3-point checklist and CASH algorithm to analyze different pigmented skin lesions. Based on preliminary results, we proposed a new modified algorithm, called the 4-point checklist, whose accuracy is similar to the CASH algorithm and whose simplicity is similar to the 3-point checklist., (© 2015 Japanese Dermatological Association.)
- Published
- 2016
- Full Text
- View/download PDF
50. Abdominopelvic post-irradiation morphea in a prostate cancer patient: the first case of an under-recognized condition.
- Author
-
di Meo N, Noal C, Trevisini S, Ulessi B, and Trevisan G
- Subjects
- Abdomen, Aged, Diagnosis, Differential, Humans, Male, Pelvis, Prostatic Neoplasms surgery, Radiodermatitis diagnosis, Radiotherapy, Adjuvant adverse effects, Scleroderma, Localized therapy, Thigh, Prostatic Neoplasms radiotherapy, Radiodermatitis etiology, Scleroderma, Localized etiology, Skin radiation effects
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.